An organizational restructuring aimed at concentrating and making effective use of management resources through an absorption merger in which the wholly owned subsidiary シーディ was the surviving company and バイオセーフ was the absorbed company. This was a merger transaction specific to the companies involved, implemented on 1 April 2022.